NCT03166761 is a Phase 4 clinical trial of Dexamethasone in Sacro-Iliac Spondylosis, sponsored by Vanderbilt University Medical Center.

Who is sponsoring NCT03166761?

NCT03166761 is sponsored by Vanderbilt University Medical Center.

What drugs are being tested in NCT03166761?

Interventions in NCT03166761: Dexamethasone, Triamcinolone Acetonide.

What condition does NCT03166761 study?

NCT03166761 studies Sacro-Iliac Spondylosis.

Is NCT03166761 still recruiting?

NCT03166761 is currently terminated. Last updated 10 July 2024.

Are results published for NCT03166761?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2024-07-10 · How we verify

NCT03166761

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Particulate Corticosteroid Versus Non-particulate Corticosteroid for Sacroiliac Joint Injection

Terminated Phase 4 Results posted Last updated 10 July 2024

What this trial tests

Phase 4 trial testing Dexamethasone in Sacro-Iliac Spondylosis in 41 participants. Terminated before completion.

Timeline

14 September 2017

Primary endpoint
28 February 2023

28 February 2023

Quick facts

Lead sponsor	Vanderbilt University Medical Center
Phase	Phase 4
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	41
Start date	14 September 2017
Primary completion	28 February 2023
Estimated completion	28 February 2023
Sites	1 location across United States

Drugs / interventions tested

Dexamethasone (dexamethasone) — full drug profile →
Triamcinolone Acetonide — full drug profile →

Conditions studied

Sacro-Iliac Spondylosis — all drugs for Sacro-Iliac Spondylosis →

Sponsor

Vanderbilt University Medical Center

Who can join

Adults 18 to 99, any sex, with Sacro-Iliac Spondylosis. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Pain Using Numeric Pain Rating Score Primary · Baseline to 3 months; Average value at month 3 reported

Numeric pain rating score, 11 point scale (0-10) filled out on a form indicating the degree of relief/discomfort after the injection. Pain was assessed monthly from baseline to 3 months following the injection. The average value at month 3 is reported.

Group	Value	95% CI
Dexamethasone	4.2	± 2.7
Triamcinolone	4.4	± 2.1

Sponsor's own description

Comparing two different corticosteroids (dexamethasone and triamcinolone) for use in sacroiliac joint injections

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Dexamethasone

Trials testing the same drug.

NCT07543458 — Therapeutics for Moderate and Severe Dengue · Phase 3 · not yet recruiting
NCT07175415 — HEM-iSMART E: Capivasertib + Venetoclax + Dexamethasone in Pediatric Patients With Relapsed or Refractory Hematological · Phase 1, PHASE2 · not yet recruiting
NCT07513129 — A Phase 1 Study Of Venetoclax, Dexamethasone, Bortezomib, And Daratumumab (VDBD) For Adolescent And Young Adult Patients · Phase 1 · not yet recruiting
NCT07444710 — Testing the Addition of an Anti-Cancer Drug, Glofitamab, to the Usual Chemotherapy Treatment (Alternating R-CHOP/R-DHAP) · Phase 1 · not yet recruiting
NCT07387926 — Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+ · Phase 1, PHASE2 · not yet recruiting

Other recruiting trials for Sacro-Iliac Spondylosis

Currently open trials in the same condition.

NCT06268704 — Particulate vs. Non-Particulate Steroid for Sacroiliac Joint Injection · Phase 4 · recruiting

Other Vanderbilt University Medical Center trials

Trials by the same sponsor.

NCT07005037 — Swallowing Impairments in ICU Survivors and Community-Dwelling Adults · not yet recruiting
NCT07527273 — Cognitive Enhancement in Recurrent Depression (The COG-D-R Study) · NA · not yet recruiting
NCT07295288 — Botox Injections in Non-Cranial Nerve VII Innervated Muscles for Facial Synkinesis · Phase 4 · not yet recruiting
NCT07431541 — Topical Carboxytherapy Paste Following Microneedling · Phase 1, PHASE2 · not yet recruiting
NCT07224711 — The Impact of Perioperative Lidocaine Infusions on Enhanced Recovery After Non-Cardiac Surgery · Phase 4 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03166761 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Vanderbilt University Medical Center
Last refreshed: 10 July 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03166761.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing